We are live on ! Find out more
CCM

Cadence Capital Management Portfolio holdings

AUM $415M
1-Year Est. Return 11.01%
This Fund
S&P 500
This Quarter Est. Return
+28.9%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
AUM
$689M
AUM Growth
+$98.9M
Cap. Flow
-$21M
Cap. Flow %
-3.04%
Top 10 Hldgs %
27.36%
Holding
473
New
51
Increased
159
Reduced
167
Closed
82

Sector Composition

Rank Sector Weight
1 Energy 32.88%
2 Healthcare 14.77%
3 Technology 12.2%
4 Industrials 9.5%
5 Financials 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
51
ExxonMobil
XOM
$642B
$2.84M 0.41%
63,578
-20,105
-24% -$902K
C icon
52
Citigroup
C
$224B
$2.82M 0.41%
55,141
-3,875
-7% -$184K
BPMP
53
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$2.6M 0.38%
226,972
-49,763
-18% -$568K
MDLZ icon
54
Mondelez International
MDLZ
$80.1B
$2.57M 0.37%
+50,294
New +$2.58M
CAT icon
55
Caterpillar
CAT
$395B
$2.48M 0.36%
19,580
-4,905
-20% -$582K
ADP icon
56
Automatic Data Processing
ADP
$109B
$2.45M 0.36%
16,484
+10,728
+186% +$1.54M
CSTL icon
57
Castle Biosciences
CSTL
$931M
$2.43M 0.35%
64,490
+2,699
+4% +$92.2K
WFC icon
58
Wells Fargo
WFC
$265B
$2.4M 0.35%
93,877
-1,374
-1% -$37.6K
CCEP icon
59
Coca-Cola Europacific Partners
CCEP
$47.9B
$2.25M 0.33%
59,620
-22,579
-27% -$886K
SHYF
60
DELISTED
The Shyft Group
SHYF
$2.23M 0.32%
132,675
+5,673
+4% +$85.7K
CL icon
61
Colgate-Palmolive
CL
$74.1B
$2.23M 0.32%
30,372
+5,988
+25% +$425K
CSBR icon
62
Champions Oncology
CSBR
$72.1M
$2.22M 0.32%
232,270
+9,956
+4% +$84.9K
ATSG
63
DELISTED
Air Transport Services Group
ATSG
$2.22M 0.32%
99,644
+46,126
+86% +$946K
PETQ
64
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2.19M 0.32%
+62,997
New +$1.77M
ITW icon
65
Illinois Tool Works
ITW
$84.8B
$2.19M 0.32%
12,520
+155
+1% +$25.3K
ZYXI
66
DELISTED
Zynex
ZYXI
$2.19M 0.32%
96,804
-33,032
-25% -$553K
MCFT icon
67
MasterCraft Boat Holdings
MCFT
$591M
$2.18M 0.32%
114,572
+4,796
+4% +$60.4K
CCS icon
68
Century Communities
CCS
$1.96B
$2.18M 0.32%
70,995
+2,973
+4% +$71K
TGT icon
69
Target
TGT
$66.8B
$2.18M 0.32%
18,156
+4,208
+30% +$480K
BSTC
70
DELISTED
BioSpecifics Technologies Corp.
BSTC
$2.16M 0.31%
35,186
-8,762
-20% -$507K
CCLD icon
71
CareCloud
CCLD
$98.6M
$2.15M 0.31%
259,416
+10,911
+4% +$73.9K
UPWK icon
72
Upwork
UPWK
$1.16B
$2.15M 0.31%
+148,637
New +$1.56M
MBUU icon
73
Malibu Boats
MBUU
$562M
$2.14M 0.31%
41,167
-14,549
-26% -$581K
BLK icon
74
Blackrock
BLK
$175B
$2.13M 0.31%
3,908
-2,028
-34% -$1.02M
OOMA icon
75
Ooma
OOMA
$588M
$2.12M 0.31%
128,726
+5,323
+4% +$66.6K

Similar funds

Cadence Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Cadence Capital Management held 473 positions worth $689M, up 17% from $590M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Cadence Capital Management withdrew a net $21M in Q2 2020, closing 82 positions and reducing 167 holdings. Its most notable exit was Shell Midstream Partners, L.P., an estimated $7.07M position sold in full.

By sector, the portfolio is most concentrated in Energy at 33% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Cadence Capital Management opened a new position in Starbucks worth $3.06M.

  • Cadence Capital Management's largest Q2 2020 buy was Starbucks: 41,650 shares worth $3.06M.
  • Cadence Capital Management added most to Enterprise Products Partners in Q2 2020, an estimated $20.2M increase.
  • Cadence Capital Management's biggest Q2 2020 reduction was Antero Midstream, cutting an estimated $6.7M.
  • Cadence Capital Management fully exited Shell Midstream Partners, L.P. in Q2 2020, selling an estimated $7.07M.
  • Cadence Capital Management's ten largest holdings make up 27% of its $689M portfolio in Q2 2020.
  • Cadence Capital Management opened 51 new positions and closed 82 in Q2 2020.
  • Cadence Capital Management's portfolio value rose 17% quarter-over-quarter to $689M.

Based on Cadence Capital Management's 13F filing for Q2 2020, filed 3 Aug 2020.